Lori Wirth

  • Dr. Lori Wirth is Medical Director of Massachusetts General Hospital’s Center for Head and Neck Cancers and Associate Professor in Medicine at Harvard Medical School. Dr. Wirth received her BA from Brown University and MD from Columbia’s College of Physicians and Surgeons. She trained at New York Presbyterian Hospital and Dana-Farber/Harvard Cancer Center.

    Dr. Wirth is an authority in advanced thyroid cancer and head and neck oncology, with expertise new therapies for head and neck and thyroid cancers. Her research focuses on clinical trials and leveraging translational data to maximize the impact of trial outcomes.

    In addition to overseeing the Center for Head and Neck Cancers, Dr. Wirth co-directs Mass General/Mass Eye and Ear’s Advanced Thyroid Cancer Clinic. Dr. Wirth is Chairperson of the International Thyroid Oncology Group, and sits on a number of national and international oncology committees, including NCCN’s Thyroid Committee and ABIM’s Medical Oncology Exam Committee.


Leave a Reply

  • Upcoming Events


    World Congress on Thyroid Cancer 3.5
    June 20 – 22, 2019
    Rome, Italy

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts


  • WCTC3.5 Steering Committee:


    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD